Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE:VGL) announces the results of
operations for the quarter ending December 31, 2013.
Business Highlights
-- Revenue grew 19% to $1.30 million up from $1.10 million in the three-
month period ended December 31, 2012
-- Bookings for the quarter were $1.15 million up 5% compared to $1.09
million in the three-month period ended December 31, 2012
-- Increased backlog to approximately $3.15 million compared to
approximately $2.76 million in the three-month period ended December 31,
2012
-- Net Income of $20 thousand compared to $132 thousand in the three month
period ended December 31, 2012
"We continue to see sales and revenue growth and we are focusing on new product
development while controlling operating costs to maintain and improve on sales
and profitability," stated Troy Griffiths, President and CEO of Vigil Health
Solutions Inc.
Financial Results
Revenue for the three-months ended December 31, 2013 was $1.30 million compared
to $1.10 million in the three-month period ended December 31, 2012, an increase
of 19%. Project revenue made up 69% of total revenue; the remaining revenue came
from follow on sales to existing customers. These sales include service and
maintenance billings and replacement products including wireless devices and
communication equipment.
Bookings for the quarter were $1.15 million up 5% compared to $1.09 million in
the three-month period ended December 31, 2012.
At December 31, 2013 Vigil had a backlog of approximately $3.15 million
(including $1.65 million in deposits and progress billings, recorded as deferred
revenue on the balance sheet) a 14% increase compared to approximately $2.76
million (including $611 thousand in deposits and progress billings, recorded as
deferred revenue on the balance sheet) at December 31, 2012. At December 31,
2013, Vigil's backlog included 37 projects at varying stages of installation and
progress billing with an average project size of $85 thousand. Projects can
include individual buildings or floors of multiple phase campus construction.
The gross margin percentage for the three months ended December 31, 2013 was 45%
compared to 50% for the three months ended December 31, 2012. Gross margin was
within management's usual expectations of margins of between 42% and 47%.
Margins have been higher in previous quarters due to a large number of one off
sales, which usually have better margins due to the lower labour component.
Expenditures for the three months ended December 31, 2013 were $568 thousand, up
34% from $424 thousand for the period ended December 31, 2012. The increase is
primarily due to increased compensation costs reflecting higher staffing levels.
Staffing is now back to normal levels similar to those seen prior to the
recession.
Net income for the three month period ended December 31, 2013 was $20 thousand,
or $0.001 per share compared to income of $132 thousand, or $0.010 per share for
the previous year. The decline in profitability reflects the small decrease in
gross profit and increasing operating costs as staffing levels rise, inline with
the increase in business activity and new product development.
Detailed financial statements along with Management Discussion and Analysis have
been filed with SEDAR (www.sedar.com).
Financial information will be mailed to entitled security holders on February
21, 2013. Or, upon notice to the Company, entitled security holders may request
a copy of financials in advance.
Summary Financial Information
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Three months ended Nine months ended
December 31, December 31, December 31, December 31,
2013 2012 2013 2012
----------------------------------------------------------------------------
Revenue $ 1,302,766 1,096,167 3,506,869 2,595,829
Cost of sales 712,687 546,081 1,856,694 1,311,835
----------------------------------------------------------------------------
590,079 550,086 1,650,175 1,283,994
Expenses 568,422 424,482 1,609,079 1,180,457
----------------------------------------------------------------------------
Income (loss) before
the following items 21,657 125,604 41,096 103,537
Other income
(expense) (1,232) 6,099 21,375 (967)
----------------------------------------------------------------------------
Income / (loss) for
the period $ 20,425 131,703 62,471 102,570
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Non-IFRS Measure
For the three months ended December 31, 2013, we are disclosing Adjusted EBITDA,
a non-IFRS financial measure, as a supplementary indicator of operating
performance. We define Adjusted EBITDA as net income before, interest, income
taxes, amortization, stock based compensation and currency gains or losses
including derivative foreign exchange differences. We are presenting the
non-IFRS financial measure in our filings because we use it internally to make
strategic decisions, forecast future results and to evaluate our performance and
because we believe that our current and potential investors and analysts use the
measure to assess current and future operating results and to make investment
decisions. It is a non-IFRS measure, may not be comparable to other companies
and it is not intended as a substitute for IFRS measures.
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Three months Nine months
ended ended
December 31, December 31, December 31, December 31,
2013 2012 2013 2012
----------------------------------------------------------------------------
Income / (loss) for
the period $ 20,425 131,703 62,471 102,570
Add / (deduct)
Foreign exchange (2,746) (9,970) (22,219) (16,731)
Derivative
exchange 4470 79 481 5,721
Interest (492) 3,792 363 11,977
Stock based
compensation 17,013 13,458 51,635 26,812
Amortization 4,281 3,814 11,947 12,043
----------------------------------------------------------------------------
22,526 11,173 42,207 39,822
----------------------------------------------------------------------------
Adjusted EBITDA $ 42,951 142,876 104,678 142,393
----------------------------------------------------------------------------
----------------------------------------------------------------------------
About Vigil Health Solutions Inc.
Vigil offers a proprietary technology platform combining software and hardware
to provide comprehensive solutions to the expanding seniors' housing market.
Vigil has established a growing presence in North America and an international
reputation for being on the leading edge of systems design and integration.
Vigil's objective is to offer solutions for the full continuum of care. Vigil's
product range includes the innovative wireless Vitality Care System(TM)
featuring discreet 'mini pendants', a nurse call system, mobile fall,
incontinence monitoring, resident check and the award-winning Vigil Dementia
System.
Certain statements contained in this news release that are not based on
historical facts may constitute forward-looking statements or forward-looking
information within the meaning of applicable securities laws ("forward-looking
statements"). These forward-looking statements are not promises or guarantees of
future performance but are only predictions that relate to future events,
conditions or circumstances or our future results, performance, achievements or
developments and are subject to substantial known and unknown risks,
assumptions, uncertainties and other factors that could cause our actual
results, performance, achievements or developments in our business or in our
industry to differ materially from those expressed, anticipated or implied by
such forward-looking statements.
Forward-looking statements include all financial guidance, disclosure regarding
possible events, conditions, circumstances or results of operations that are
based on assumptions about future economic conditions, courses of action and
other future events. We caution you not to place undue reliance upon any such
forward-looking statements, which speak only as of the date they are made. These
forward-looking statements appear in a number of different places in this
presentation and can be identified by words such as "may", "estimates",
"projects", "expects", "intends", "believes", "plans", "anticipates", or their
negatives or other comparable words. Forward-looking statements include
statements regarding the outlook for our future operations, plans and timing for
the introduction or enhancement of our services and products, statements
concerning strategies or developments, statements about future market
conditions, supply conditions, end customer demand conditions, channel inventory
and sell through, revenue, gross margin, operating expenses, profits, forecasts
of future costs and expenditures, the outcome of legal proceedings, and other
expectations, intentions and plans that are not historical fact.
The risk factors and uncertainties that may affect our actual results,
performance, achievements or developments are many and include, amongst others,
our ability to develop our sales force and generate revenue, the length of the
sales cycle, management of the Company's growth, ability to recruit and retain
staff, fluctuations in demand for current and future products, our ability to
develop, manufacture, supply and market existing and new products that meet the
needs of customers, volatility in the exchange rate, ability to secure
financing, ability to secure product liability insurance, the continuous
commitment of our customers, increased competition, changes in regulation and
reliance on third party suppliers. These risk factors and others are discussed
in the Risks and Uncertainties section of our "Management Discussion and
Analysis" segment of our fiscal 2013 Annual Report. Many of these factors and
uncertainties are beyond the control of the Company. Consequently, all
forward-looking statements in this news release are qualified by this cautionary
statement and there can be no assurance that actual results, performance,
achievements or developments anticipated by the Company will be realized.
Forward-looking statements are based on management's current plans, estimates,
projections, beliefs and opinions and, except as required by law, the Company
does not undertake any obligation to update forward-looking statements should
the assumptions related to these plans, estimates, projections, beliefs and
opinions change.
The TSX Venture Exchange has not reviewed and does not accept responsibility for
the adequacy or accuracy of this release.
FOR FURTHER INFORMATION PLEASE CONTACT:
Vigil Health Solutions Inc.
Troy Griffiths
President and CEO
(250) 383-6900
(250) 383-6999 (FAX)
information@vigil.com
www.vigil.com
Vigil Health Solutions (TSXV:VGL)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Vigil Health Solutions (TSXV:VGL)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
